Role of Phosphodiesterase Type 5 Inhibitor on Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms

Korean Journal of Andrology ◽

10.5534/kja.2011.29.2.91 ◽

2011 ◽

Vol 29 (2) ◽

pp. 91 ◽

Author(s):

Sang Deuk Kim ◽

Jong Kwan Park

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Download Full-text

The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia

Türk Üroloji Dergisi/Turkish Journal of Urology ◽

10.5152/tud.2013.064 ◽

2013 ◽

Vol 39 (4) ◽

pp. 264-269

Author(s):

Mehmet Umul ◽

Tekin Ahmet Serel

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phosphodiesterase Type 5 Inhibitors ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Download Full-text

EFFECT OF PHOSPHODIESTERASE TYPE 5 INHIBITOR USE ON LOWER URINARY TRACT SYMPTOMS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA (BPH): RESULTS FROM THE BPH REGISTRY

The Journal of Urology ◽

10.1016/s0022-5347(08)60408-5 ◽

2008 ◽

Vol 179 (4S) ◽

pp. 142-142

Author(s):

Raymond C Rosen ◽

John T Wei ◽

Martin Miner ◽

Claus G Roehrborn ◽

Allen D Seftel

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Download Full-text

The Use of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia ◽

10.1002/9781118437889.ch10 ◽

2014 ◽

pp. 113-128

Author(s):

Casey Lythgoe ◽

Kevin T. McVary

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phosphodiesterase Type 5 Inhibitors ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Download Full-text

Role of the impairment of oxidative metabolism in pathogenesis of lower urinary tract symptoms with benign prostatic hyperplasia and their treatment by α1-adrenoblocker alfuzosin

Mitochondrion ◽

10.1016/s1567-7249(03)00061-8 ◽

2003 ◽

Vol 3 (2) ◽

pp. 67-73 ◽

Author(s):

E.L Vishnevsky ◽

M.N Kondrashova ◽

D.Y Pushkar ◽

E Vishnevsky ◽

A.A Demidov ◽

...

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Oxidative Metabolism ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Download Full-text

The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia

World Journal of Urology ◽

10.1007/s00345-002-0247-6 ◽

2002 ◽

Vol 19 (6) ◽

pp. 426-435 ◽

Author(s):

Kurt Dreikorn

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Download Full-text

Re: A Placebo-Controlled Study Investigating the Efficacy and Safety of the Phosphodiesterase Type 5 Inhibitor UK-369,003 for the Treatment of Men With Lower Urinary Tract Symptoms Associated With Clinical Benign Prostatic Hyperplasia

The Journal of Urology ◽

10.1016/j.juro.2011.09.107 ◽

2012 ◽

Vol 187 (1) ◽

pp. 213-214

Author(s):

Steven A. Kaplan

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Efficacy And Safety ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Download Full-text

The role of combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia

Current Urology Reports ◽

10.1007/s11934-003-0084-1 ◽

2003 ◽

Vol 4 (4) ◽

pp. 276-281 ◽

Author(s):

Chris M. Gonzalez ◽

Kevin T. McVary

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Combination Therapy ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Download Full-text

Re: The Role of Inflammation in Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH) and its Potential Impact on Medical Therapy

The Journal of Urology ◽

10.1016/j.juro.2015.12.039 ◽

2016 ◽

Vol 195 (3) ◽

pp. 689-692

Author(s):

Steven A. Kaplan

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Medical Therapy ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Potential Impact ◽

Download Full-text

The role of urodynamic study in the evaluation and management of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia

Urology ◽

10.1016/s0090-4295(96)00249-x ◽

1996 ◽

Vol 48 (5) ◽

pp. 668-675 ◽

Author(s):

Glenn S. Gerber

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urodynamic Study ◽

Urinary Tract Symptoms ◽

Download Full-text

The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia

BJU International ◽

10.1111/j.1464-410x.2004.04962.x ◽

2004 ◽

Vol 94 (3) ◽

pp. 338-344 ◽

Author(s):

Glenn S. Gerber ◽

John M. Fitzpatrick

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Serenoa Repens ◽

Urinary Tract Symptoms ◽

Download Full-text